Presence of Tertiary Lymphoid Structures in Kidney Biopsies Is Associated with Poorer Treatment Response in Lupus Nephritis

Background: Renal treatment response is a key prognostic factor in lupus nephritis (LN), but predictive tools are limited. Tertiary lymphoid structures (TLSs) are inducible structures in chronic inflammation that support local immune activation and have been linked to immunotherapy response in tumors. Their association with treatment response in LN, however, remains unclear. Methods: This cohort study included 198 Chinese patients with first-time biopsy-proven LN of class III, IV, V, III+V, or IV+V, diagnosed at the First Affiliated Hospital of Sun Yat-sen University between January 1, 2017, and December 31, 2023. All patients had sufficient renal tissue for multiplex immunofluorescence staining and available follow-up data. Multiplex immunofluorescence staining was performed on renal tissue specimens from eligible patients. TLSs were identified as nodular inflammatory infiltrates containing organized CD3+ and CD20+ cells. Based on the presence of CD21+ cells and organized Ki67+ proliferating cells, TLSs were further classified into immature and mature types. Treatment efficacy was evaluated according to the 2024 KDIGO clinical practice guidelines, with complete response (CR), partial response (PR), and no response (NR) assessed within 12 months. The association between TLSs and treatment response in LN was subsequently analyzed. Results: Among 198 LN patients, 89 (45.0%) had no TLSs, 80 (40.4%) had immature TLSs, and 29 (14.6%) had mature TLSs. Among these 198 patients, 113 (57.1%) achieved CR, 48 (24.2%) had PR, and 37 (18.7%) showed NR. Compared to patients without TLSs, those with TLSs showed higher proteinuria levels, greater hypoalbuminemia prevalence, and elevated Chronicity Index scores in renal biopsy. Additionally, TLS-positive patients were less likely to achieve CR than TLS-negative patients (50.5% vs. 65.2%, P=0.038). Notably, the NR rate was significantly higher in patients with mature TLSs compared to those without (34.5% vs. 16.0%, P=0.018). Conclusion: The detection of TLSs in renal biopsies correlates with reduced treatment responsiveness in LN, suggesting their potential role in defining distinct LN subphenotypes.

Authors

Institutions

Publication Details

Journal
Journal of the American Society of Nephrology
Published
2025-10-01
DOI
https://doi.org/10.1681/asn.20252qfp1h38
Primary Topic
Systemic Lupus Erythematosus Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Presence of Tertiary Lymphoid Structures in Kidney Biopsies Is Associated with Poorer Treatment Response in Lupus Nephritis

Ru Tang, Xiaoyuan Jiang, Wei Chen, Xiaolei Shi et al.
Journal of the American Society of Nephrology
Systemic Lupus Erythematosus Research
article

Presence of Tertiary Lymphoid Structures in Kidney Biopsies Is Associated with Poorer Treatment Response in Lupus Nephritis

Ru Tang, Xiaoyuan Jiang, Wei Chen, Xiaolei Shi, Xiuzhi Jia, Ruoxi Zhang, Xi Xia
article en

Abstract

Background: Renal treatment response is a key prognostic factor in lupus nephritis (LN), but predictive tools are limited. Tertiary lymphoid structures (TLSs) are inducible structures in chronic inflammation that support local immune activation and have been linked to immunotherapy response in tumors. Their association with treatment response in LN, however, remains unclear. Methods: This cohort study included 198 Chinese patients with first-time biopsy-proven LN of class III, IV, V, III+V, or IV+V, diagnosed at the First Affiliated Hospital of Sun Yat-sen University between January 1, 2017, and December 31, 2023. All patients had sufficient renal tissue for multiplex immunofluorescence staining and available follow-up data. Multiplex immunofluorescence staining was performed on renal tissue specimens from eligible patients. TLSs were identified as nodular inflammatory infiltrates containing organized CD3+ and CD20+ cells. Based on the presence of CD21+ cells and organized Ki67+ proliferating cells, TLSs were further classified into immature and mature types. Treatment efficacy was evaluated according to the 2024 KDIGO clinical practice guidelines, with complete response (CR), partial response (PR), and no response (NR) assessed within 12 months. The association between TLSs and treatment response in LN was subsequently analyzed. Results: Among 198 LN patients, 89 (45.0%) had no TLSs, 80 (40.4%) had immature TLSs, and 29 (14.6%) had mature TLSs. Among these 198 patients, 113 (57.1%) achieved CR, 48 (24.2%) had PR, and 37 (18.7%) showed NR. Compared to patients without TLSs, those with TLSs showed higher proteinuria levels, greater hypoalbuminemia prevalence, and elevated Chronicity Index scores in renal biopsy. Additionally, TLS-positive patients were less likely to achieve CR than TLS-negative patients (50.5% vs. 65.2%, P=0.038). Notably, the NR rate was significantly higher in patients with mature TLSs compared to those without (34.5% vs. 16.0%, P=0.018). Conclusion: The detection of TLSs in renal biopsies correlates with reduced treatment responsiveness in LN, suggesting their potential role in defining distinct LN subphenotypes.

Journal of the American Society of NephrologyVol. 36(10S)
Sun Yat-sen University (CN), The First Affiliated Hospital, Sun Yat-sen University (CN)
Openalex Percentile: Top 47%
Systemic Lupus Erythematosus Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.